Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SYRE
SYRE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SYRE News
Cameron Turtle Sells Shares in Spyre
1d ago
Yahoo Finance
Spyre Therapeutics Grants Stock Options and RSUs to Employees
5d ago
Newsfilter
Spyre Therapeutics Shares Drop 10% Following Director's Stock Sale
Jun 24 2026
seekingalpha
Multiple Companies Show Strong Stock Performance
Jun 20 2026
NASDAQ.COM
Spyre Therapeutics Grants Stock Options to Employees
Jun 05 2026
Newsfilter
Biotech Sector Approaches Critical Phase 2 Milestones
May 28 2026
Newsfilter
HighVista Strategies Cuts Stake in Viridian Therapeutics by $7 Million
May 17 2026
Yahoo Finance
Spyre Therapeutics Q1 Earnings Miss Expectations Amid $403M Stock Offering
May 05 2026
seekingalpha
Spyre Therapeutics (SYRE.US) Officer Plans to Sell $5.83 Million in Common Stock via Form 144
May 01 2026
moomoo
Spyre Therapeutics Grants Stock Options to Employees
May 01 2026
Newsfilter
Spyre Therapeutics Prices Public Offering at $62 per Share
Apr 15 2026
NASDAQ.COM
Spyre Therapeutics Upsizes Public Offering to Raise $403 Million
Apr 15 2026
seekingalpha
Spyre Therapeutics Prices $403 Million Public Offering
Apr 15 2026
Yahoo Finance
Spyre Therapeutics Prices Public Offering at $62 per Share
Apr 15 2026
Newsfilter
Spyre Therapeutics Launches $300 Million Public Offering
Apr 14 2026
NASDAQ.COM
Spyre Therapeutics Launches $300M Public Offering to Fund Drug Development
Apr 13 2026
seekingalpha
Show More News
